the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Clinical trial NCT07380646 · RECRUITING

Trial details

NCT number: NCT07380646
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leucogen Ribociclib Neutropenia (Low White Blood Cell Count)Breast Cancer

Start date: 2026-01-07
Primary completion: 2028-01-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.